Clearside BioMedical is an ophthalmic company that specializes in the research, development, and commercialization of therapeutic products.
Clearside Biomedical has raised $3.0M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in July 2026.
Clearside Biomedical's investors include Cormorant Asset Management, Hatteras Venture Partners, Perceptive Advisors, HealthCare Royalty Partners, Rock Springs Capital.
Clearside Biomedical is headquartered in Alpharetta, United States.
Clearside BioMedical is an ophthalmic company that specializes in the research, development, and commercialization of therapeutic products.
Clearside Biomedical is at the Post-IPO Debt stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Clearside Biomedical — Funding & Investors." VCBacked, July 14, 2026, https://www.vcbacked.co/company/clearside-biomedical. Accessed September 29, 2026.
VCBacked. (2026). Clearside Biomedical — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/clearside-biomedical
{{cite web |title=Clearside Biomedical — Funding & Investors |url=https://www.vcbacked.co/company/clearside-biomedical |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated